Third View Private Wealth »

Ligand Pharmaceuticals In shares owned by Third View Private Wealth

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Third View Private Wealth from 13F filings

Historical chart of Third View Private Wealth investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Third View Private Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Third View Private Wealth

Quarter filed Position value Share count Share price at filing
2026-06-30 $242k 767 316.09

More positions owned by Third View Private Wealth

NVIDIA Corporation (NVDA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Visa Com Cl A (V)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Growth Etf (VUG)
Boeing Company (BA)
Netflix (NFLX)
Oracle Corporation (ORCL)

View all positions for Third View Private Wealth

Top funds holding Ligand Pharmaceuticals In

BlackRock
Invesco
Vanguard Portfolio Management
Jupiter Topco
Henderson Group
Vanguard Capital Management
State Street Corporation
FMR
Franklin Resources
Congress Asset Management
Geode Capital Management
Nomura Asset Management International
Chicago Capital
Stephens Investment Management Group
Dimensional Fund Advisors

View all funds holding Ligand Pharmaceuticals In